Management of male breast cancer

Main Article Content

Nikolay V. Dimitro v (1*), Sunil Nagpal (2), Shalini Chitneni (3)

1 Michigan State University, Department of Medicine, Division of Hematology/Oncology, East Lansing, Michigan, United States.
2 Michigan State University, Department of Medicine, Division of Hematology/Oncology, East Lansing, Michigan, .
3 Michigan State University, Department of Medicine, Division of Hematology/Oncology, East Lansing, Michigan, United States.
(*) Corresponding Author:
Nikolay V. Dimitro v
dimitrov@msu.edu

Abstract

The management of male breast cancer is still under discussion due to lack of information from prospective, randomized clinical trials and low incidence of this disease. Current management is based largely on extrapolation from data related to treatment of female breast cancer. Over the last two decades, several review articles have discussed mainly retrospective and anecdotal data related to hormonal and chemotherapy treatment modalities. In this review, we present the most recent information and future considerations related to the management of male breast cancer. In addition to the conventional treatment options we will discuss the possible role of targeted therapy. Establishing a national or global registry for male breast cancer will provide more precise information about the natural history of the disease and will facilitate the design and execution of prospective, randomized multicenter clinical trials.

Downloads month by month

Downloads

Download data is not yet available.

Article Details

How to Cite
Dimitro v, N. V., Nagpal, S., & Chitneni, S. (2011). Management of male breast cancer. Oncology Reviews, 2(1), 44-52. Retrieved from http://www.oncologyreviews.org/index.php/or/article/view/oncol.2008.44